3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
申请人:Boston Biomedical, Inc.
公开号:US10017488B2
公开(公告)日:2018-07-10
The present invention provides a compound of the following Formula (1) or a pharmaceutically acceptable salt thereof:
wherein X is an oxygen atom and the like; Y is —CO—, —SO2— and the like; R1 is an optionally-substituted C1-6 alkyl group, an optionally-substituted C1-6 alkylcarbonyl group and the like; R2 is an optionally-substituted C1-6 alkyl group, an optionally-substituted C1-6 alkoxy group, an optionally-substituted amino group, an optionally-substituted 5- to 12-membered monocyclic or polycyclic saturated heterocyclic group and the like; R3, R4, R5, and R6 are independently a hydrogen atom and the like which exhibits excellent effects in suppressing the proliferation and sphere-forming ability of cancer cells, and can be useful as an antitumor drug or cell growth inhibitor.
本发明提供了下式(1)的化合物或其药学上可接受的盐:
其中 X 是氧原子等;Y 是 -CO-、-SO2- 等;R1 是任选取代的 C1-6 烷基、任选取代的 C1-6 烷基羰基等;R2 是任选取代的 C1-6 烷基、任选取代的 C1-6 烷氧基、任选取代的氨基、任选取代的 5 至 12 元单环或多环饱和杂环基等;R3、R4、R5 和 R6 独立地为氢原子等,在抑制癌细胞增殖和癌细胞球形成能力方面具有优异的效果,可用作抗肿瘤药物或细胞生长抑制剂。